RO82518B1 - Process for obtaining the vaccine against carre disease - Google Patents

Process for obtaining the vaccine against carre disease

Info

Publication number
RO82518B1
RO82518B1 RO107999A RO10799982A RO82518B1 RO 82518 B1 RO82518 B1 RO 82518B1 RO 107999 A RO107999 A RO 107999A RO 10799982 A RO10799982 A RO 10799982A RO 82518 B1 RO82518 B1 RO 82518B1
Authority
RO
Romania
Prior art keywords
carre
disease
obtaining
vaccine against
virus
Prior art date
Application number
RO107999A
Other languages
Romanian (ro)
Inventor
Victor Patrascu Ionel
Muntean Ion
Ciobanu Maria
Original Assignee
Victor Patrascu Ionel
Muntean Ion
Ciobanu Maria
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Victor Patrascu Ionel, Muntean Ion, Ciobanu Maria filed Critical Victor Patrascu Ionel
Priority to RO107999A priority Critical patent/RO82518B1/en
Publication of RO82518B1 publication Critical patent/RO82518B1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Procedeu de obtinere a vaccinului contra bolii Carre, prin recoltarea mediului de cultura si a celulelor infectate cu acest virus cînd în fenomenul citopatic a atins 70...80% din monostrat, centrifugarea si conservarea la -100...-196 degree C pîna la liofilizare în diluant protector SPGA sau peptona-lactoza, care consta în faptul ca virusul folosit este tulpina Canine Distemper Virus-MC clona 31, înregistrata în colectia Centrului de cercetari si biopreparate pentru pasari si animale mici - Voluntari sun nr. 31.Procedure for obtaining the vaccine against Carre disease by harvesting the culture medium and cells infected with this virus when in the cytopathic phenomenon reached 70 ... 80% of the monolayer, centrifuging and preserving at -100 ... 196 degrees Celsius to lyophilization in SPGA protector diluent or peptone-lactose, which consists in the fact that the virus used is the Canine Distemper Virus-MC clone 31 strain, registered in the collection of the Center for Research and Biopreparations for Birds and Small Animals - volunteers call no. 31.

RO107999A 1982-06-28 1982-06-28 Process for obtaining the vaccine against carre disease RO82518B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RO107999A RO82518B1 (en) 1982-06-28 1982-06-28 Process for obtaining the vaccine against carre disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RO107999A RO82518B1 (en) 1982-06-28 1982-06-28 Process for obtaining the vaccine against carre disease

Publications (1)

Publication Number Publication Date
RO82518B1 true RO82518B1 (en) 1983-08-30

Family

ID=40903286

Family Applications (1)

Application Number Title Priority Date Filing Date
RO107999A RO82518B1 (en) 1982-06-28 1982-06-28 Process for obtaining the vaccine against carre disease

Country Status (1)

Country Link
RO (1) RO82518B1 (en)

Similar Documents

Publication Publication Date Title
Papas et al. Type C virus in lymphosarcoma in northern pike (Esox lucius)
Jordan et al. Inactivation of some animal viruses with gamma radiation from cobalt-60.
DE3889138D1 (en) Influenza vaccine.
ATE335809T1 (en) CAT IL-2 INDEPENDENT T CELLS
ES336810A1 (en) Feline virus vaccines obtained by propagation and serial passage attenuation of virulent feline viruses in diploid feline embryo tissue cell serial passage subculture strains
RO79525B (en) Process for preparing an anti-influenza vaccine
JPS5527178A (en) Live influenza virus vaccine
JPS55147227A (en) Preparrtion of attenuated live mumps vaccine
FI59812B (en) FOERFARANDE FOER ISOLERING AV EN NY RABIESVIRUSSTAM
RO82518B1 (en) Process for obtaining the vaccine against carre disease
DK1002055T3 (en) Recovery of virus from cell culture using a hypertonic saline solution
Sonstegard et al. Epidemiological model for passive transfer of IPNV by homeotherms
GB1143996A (en) Antiviral vaccine
BG40473A3 (en) Herbicide means
ATE112490T1 (en) LIVE NEWCASTLE DISEASE VIRUS VACCINE.
DE3272729D1 (en) Hepatitis-a viruses adapted to human fibroblast cells
Chu et al. Pathogenicity and Immunogenicity Herpes Simplex Virus Strains Propagated in Rabbit Kidney Tissue.
SU1131900A1 (en) Inactivator for microviruses
Stagg et al. Superinfection of established Theileria-infected bovid cell lines with Theileria parva sporozoites
ES482549A0 (en) A METHOD FOR THE PREPARATION OF A HERPES VIRUS COMPOSITION
Chung et al. Natural cell-mediated cytotoxicity to cells infected with infectious bovine rhinotracheitis virus
ATE26267T1 (en) PYRIMIDINE DERIVATIVES, EQUIPPED WITH ANTIVIRAL ACTION.
MX9206216A (en) PREPARATION OF ANTIGENS AND VACCINES OF THE VIRUS OF THE MYSTERIOUS DISEASE, ANTIGENS AND VACCINES OBTAINED FOR THE PREVENTION OF SUCH DISEASE
RO86744B1 (en) Avian salmonela preventing vaccine
Tircomnicu et al. Aspects of the behavior of some corn hybrids in relation to Helminthosporium turcicum Pass. in Rumania